JPS5111770A - Bitamin e shibozokukarubonsanesuteruno goseiho - Google Patents

Bitamin e shibozokukarubonsanesuteruno goseiho

Info

Publication number
JPS5111770A
JPS5111770A JP49081692A JP8169274A JPS5111770A JP S5111770 A JPS5111770 A JP S5111770A JP 49081692 A JP49081692 A JP 49081692A JP 8169274 A JP8169274 A JP 8169274A JP S5111770 A JPS5111770 A JP S5111770A
Authority
JP
Japan
Prior art keywords
shibozokukarubonsanesuteruno
goseiho
bitamin
shibozokukarubonsanesuteruno goseiho
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP49081692A
Other languages
English (en)
Other versions
JPS6020388B2 (ja
Inventor
Tetsuya Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eezai Kk
Eisai Co Ltd
Original Assignee
Eezai Kk
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eezai Kk, Eisai Co Ltd filed Critical Eezai Kk
Priority to JP49081692A priority Critical patent/JPS6020388B2/ja
Priority to US05/596,569 priority patent/US4039559A/en
Priority to GB29973/75A priority patent/GB1511366A/en
Priority to DE2532000A priority patent/DE2532000C2/de
Priority to FR7522521A priority patent/FR2278334A1/fr
Publication of JPS5111770A publication Critical patent/JPS5111770A/ja
Publication of JPS6020388B2 publication Critical patent/JPS6020388B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
JP49081692A 1974-07-18 1974-07-18 ビタミンｅ脂肪族カルボン酸エステルの合成法 Expired JPS6020388B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP49081692A JPS6020388B2 (ja) 1974-07-18 1974-07-18 ビタミンｅ脂肪族カルボン酸エステルの合成法
US05/596,569 US4039559A (en) 1974-07-18 1975-07-16 Aliphatic carboxylic acid esters of Vitamin E and process for preparation thereof
GB29973/75A GB1511366A (en) 1974-07-18 1975-07-17 Aliphatic carboxylic acid esters of vitamin e and process for preparation thereof
DE2532000A DE2532000C2 (de) 1974-07-18 1975-07-17 α-Tocopherylpivalat und Verfahren zu seiner Herstellung
FR7522521A FR2278334A1 (fr) 1974-07-18 1975-07-18 Esters d'acides carboxyliques aliphatiques de la vitamine e, leur procede de preparation et leur application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49081692A JPS6020388B2 (ja) 1974-07-18 1974-07-18 ビタミンｅ脂肪族カルボン酸エステルの合成法

Publications (2)

Publication Number Publication Date
JPS5111770A true JPS5111770A (en) 1976-01-30
JPS6020388B2 JPS6020388B2 (ja) 1985-05-21

Family

ID=13753401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49081692A Expired JPS6020388B2 (ja) 1974-07-18 1974-07-18 ビタミンｅ脂肪族カルボン酸エステルの合成法

Country Status (5)

Country Link
US (1) US4039559A (ja)
JP (1) JPS6020388B2 (ja)
DE (1) DE2532000C2 (ja)
FR (1) FR2278334A1 (ja)
GB (1) GB1511366A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2859961B2 (ja) * 1991-06-04 1999-02-24 マリゲン ソシエテ アノニム ビタミンｄおよびビタミンｅ化合物の新規生体界面活性エステルおよびホスファチド、それらの製造方法、それらの化合物を含有する自然分散性剤、腫瘍の治療へのそれらの利用法

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2420523A1 (fr) * 1978-03-23 1979-10-19 Nisshin Flour Milling Co Nouveaux derives acides et esters et leur application comme agents antiulcere
US4221810A (en) * 1978-03-23 1980-09-09 Nisshin Flour Milling Co., Ltd. Antiulcer compounds
US5502224A (en) * 1991-06-04 1996-03-26 Marigen, S.A. Biotenside esters and phosphatides with vitamin-D and vitamin-E compounds
EP0636618A1 (de) * 1991-06-04 1995-02-01 Marigen S.A. Spontan dispergierbare Konzentrate und Mikroemulsionen mit Vitamin-E-Verbindungen zur Herstellung von Arzneimitteln mit Antitumoraler Wirksamkeit
KR950007045B1 (ko) * 1992-04-14 1995-06-30 주식회사태평양 폴리에톡실레이티드 비타민 e를 함유한 피부화장료
US5990322A (en) * 1999-03-09 1999-11-23 Sk Corporation Alpha-tocopherol cyclopropylates, the new vitamin E derivatives and method for producing the same
DE69909960T2 (de) * 1999-03-10 2004-06-03 Sk Corp. Cyclopropylestern von Alfa-Tocopherol, Vitamin E Derivate und Verfahren zu deren Herstellung
CN1329387C (zh) * 1999-03-16 2007-08-01 Sk株式会社 α－维生素E环丙烷羧酸酯、维生素E衍生物及其制备方法
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US7048952B2 (en) * 2002-05-21 2006-05-23 Morinda, Inc. Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
WO2002083159A1 (en) * 2001-04-17 2002-10-24 Morinda, Inc. Palliative effects of morinda citrifolia oil and juice
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US6716873B1 (en) * 2003-03-20 2004-04-06 Yasoo Health Inc. Tocopherol ester compounds
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
US20050106275A1 (en) * 2003-05-02 2005-05-19 Chen Su Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
WO2006028826A2 (en) * 2004-09-01 2006-03-16 Paulus Wang Morinda citrifolia-based formulations and methods for weight management
US20060141076A1 (en) * 2004-11-01 2006-06-29 Palu Afa K Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20060222716A1 (en) * 2005-04-01 2006-10-05 Joseph Schwarz Colloidal solid lipid vehicle for pharmaceutical use
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070237848A1 (en) * 2005-12-21 2007-10-11 Brad Rawson MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US20080226758A1 (en) * 2006-11-28 2008-09-18 Shixin Deng Lipoxygenase and Cyclooxygenase Inhibition
US20080213415A1 (en) * 2007-02-08 2008-09-04 Palu Afa K Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475977A (de) * 1965-10-12 1969-07-31 Hoffmann La Roche Verfahren zur Herstellung eines Chromanderivates
CH547278A (de) * 1971-01-11 1974-03-29 Hoffmann La Roche Verfahren zur herstellung von chromanderivaten.
JPS5118954B2 (ja) * 1972-02-04 1976-06-14
GB1394260A (en) * 1972-10-24 1975-05-14 Ici Ltd Esters of alpha-tocopherol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2859961B2 (ja) * 1991-06-04 1999-02-24 マリゲン ソシエテ アノニム ビタミンｄおよびビタミンｅ化合物の新規生体界面活性エステルおよびホスファチド、それらの製造方法、それらの化合物を含有する自然分散性剤、腫瘍の治療へのそれらの利用法

Also Published As

Publication number Publication date
US4039559A (en) 1977-08-02
DE2532000A1 (de) 1976-02-05
FR2278334B1 (ja) 1978-11-10
FR2278334A1 (fr) 1976-02-13
JPS6020388B2 (ja) 1985-05-21
DE2532000C2 (de) 1984-11-22
GB1511366A (en) 1978-05-17

Similar Documents

Publication Publication Date Title
JPS5111770A (en) Bitamin e shibozokukarubonsanesuteruno goseiho
CS598377A2 (en) Zpusob vyroby novych heterocyklickych sloucenin
GB1539190A (en) Aminonitropyridines
CS62475A2 (en) Elektricky stroj chlazeny plynem
AU8747775A (en) 1-substituted-4-benzylidenepiperidines
AU8751375A (en) 3-chloro-2-oxazolidinones
GB1482343A (en) Carbonyl-aldiminomethanephosphonates
AU8677475A (en) Phenylethanolamines
AU8349775A (en) Beer-wort
CS324775A2 (en) Zpusob vyroby ferromagnetickeho kyslicniku chromiciteho
JPS5118775A (en) Ramineetofuirumuno seizohoho
AU7973175A (en) Pyroscrubber
JPS5119183A (en) Kajutono genekikishakukongokyokyuhoshiki
AU8582275A (en) Aptiperspirant
JPS5118111A (en) Fuanteimizugarasuno fukugogurautokoho
AU8427775A (en) Thieno- and furanopyridines
AU8421275A (en) D-homo-steroids
AU8446875A (en) Diisocyanatodiketenes
JPS5114031A (en) Kogakusenino setsuzokuhoho
JPS516967A (en) Bitamin e nikochinsanesuteruno seizoho
JPS5112709A (en) Fuirutasonyu jokyohoshiki
JPS5119831A (en) Epuronheno senisokuno makiagariboshihoho
JPS5114709A (en) Torenchaano chokushinyoanteisochi
JPS5115983A (en) Handotaisochino seizohoho
GB1484002A (en) 11-aminoalkylmorphanthridin-11-ols